At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Financial incentivesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Financial Incentives to Improve Adherence to Inhaled Asthma Medications in Children and Young People With Asthma
In Brief
A clinical study evaluating Financial incentives for Asthma in Children and Medication Adherence. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The aim of this pilot randomised controlled trial is to assess the effectiveness of a short-term financial incentives intervention at bringing about behaviour change, namely short-medium term improvements in inhaled corticosteroid (ICS) adherence and asthma control in children and young people (CYP) with asthma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma in Children, Medication Adherence
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartJul 2022
Primary CompletionJul 2023
Study CompletionSep 2023
TodayJul 2026
First PostedApr 11, 2022
Enrollment StartJul 18, 2022
Primary CompletionJul 11, 2023
Study CompletionSep 28, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.2 years ago
Interventions
Financial incentivesbehavioral
Financial incentives dependent upon adherence will be given to participants alongside additional EMD associated app features for 12-weeks.